BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8672259)

  • 1. Subcellular distribution and photocytotoxicity of aluminium phthalocyanines and haematoporphyrin derivative in cultured human meningioma cells.
    Malham GM; Thomsen RJ; Finlay GJ; Baguley BC
    Br J Neurosurg; 1996 Feb; 10(1):51-7. PubMed ID: 8672259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.
    Dias LM; Sharifi F; de Keijzer MJ; Mesquita B; Desclos E; Kochan JA; de Klerk DJ; Ernst D; de Haan LR; Franchi LP; van Wijk AC; Scutigliani EM; Cavaco JEB; Tedesco AC; Huang X; Pan W; Ding B; Krawczyk PM; Heger M;
    J Photochem Photobiol B; 2021 Mar; 216():112146. PubMed ID: 33601256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible advantages of aluminum-chloro-tetrasulfonated phthalocyanine over hematoporphyrin derivative as a photosensitizer in photodynamic therapy.
    Koshida K; Hisazumi H; Komatsu K; Hirata A; Uchibayashi T
    Urol Res; 1993; 21(4):283-8. PubMed ID: 8212418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro comparison of the photodynamic activity of meso-tetra (m-hydroxyphenyl) chlorin and hematoporphyrin derivative].
    Rezzoug H; Barberi-Heyob M; Merlin JL; Bolotine L; Lignon D; Guillemin F
    Bull Cancer; 1996 Oct; 83(10):816-22. PubMed ID: 8952631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hematoporphyrin derivative-mediated photodynamic therapy for human nasopharyngeal carcinoma: a comparative study with CNE2 and C666-1 cell lines in vitro].
    Yang XM; Luo RC; Ma HJ; Li LB; Ding XM; Yan X; Lü CW; Zhou XP
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):165-7. PubMed ID: 17355926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
    Brasseur N; Ouellet R; La Madeleine C; van Lier JE
    Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The photodynamic effect of far-red range phthalocyanines (AlPc and Pc green) supported by electropermeabilization in human gastric adenocarcinoma cells of sensitive and resistant type.
    Zielichowska A; Saczko J; Garbiec A; Dubińska-Magiera M; Rossowska J; Surowiak P; Choromańska A; Daczewska M; Kulbacka J; Lage H
    Biomed Pharmacother; 2015 Feb; 69():145-52. PubMed ID: 25661351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photosensitization of lymphoblastoid cells with phthalocyanines at different saturating incubation times.
    Gomes ER; Cruz T; Lopes CF; Carvalho AP; Duarte CB
    Cell Biol Toxicol; 1999; 15(4):249-60. PubMed ID: 10696824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells.
    Messmann H; Geisler M; Gross U; Abels C; Szeimies RM; Steinbach P; Knüchel R; Doss M; Schölmerich J; Holstege A
    Br J Cancer; 1997; 76(7):878-83. PubMed ID: 9328146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Photophysical properties and photodynamic activity of nanostructured aluminium phthalocyanines].
    Udartseva OO; Lobanov AV; Andeeva ER; Dmitrieva GS; Mel'nikov MIa; Buravkova LB
    Biofizika; 2014; 59(6):1051-60. PubMed ID: 25715609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photocytotoxic efficacy of sulphonated species of aluminium phthalocyanine against cell monolayers, multicellular spheroids and in vivo tumours.
    Chan WS; West CM; Moore JV; Hart IR
    Br J Cancer; 1991 Nov; 64(5):827-32. PubMed ID: 1931602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of phthalocyanine photosensitizers against human glioblastoma in vitro.
    Abernathey CD; Anderson RE; Kooistra KL; Laws ER
    Neurosurgery; 1987 Oct; 21(4):468-73. PubMed ID: 3683779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low-density lipoprotein as a delivery system for photosensitizers: implications for photodynamic therapy of atherosclerosis.
    de Vries HE; Moor AC; Dubbelman TM; van Berkel TJ; Kuiper J
    J Pharmacol Exp Ther; 1999 Apr; 289(1):528-34. PubMed ID: 10087046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photophysical and redox properties of a series of phthalocyanines: relation with their photodynamic activities on TF-1 and Daudi leukemic cells.
    Daziano JP; Steenken S; Chabannon C; Mannoni P; Chanon M; Julliard M
    Photochem Photobiol; 1996 Oct; 64(4):712-9. PubMed ID: 8863479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of porphyrin C analogues for photodynamic therapy of cerebral glioma.
    Karagianis G; Hill JS; Stylli SS; Kaye AH; Varadaxis NJ; Reiss JA; Phillips DR
    Br J Cancer; 1996 Feb; 73(4):514-21. PubMed ID: 8595167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminium-phthalocyanine chloride nanoemulsions for anticancer photodynamic therapy: Development and in vitro activity against monolayers and spheroids of human mammary adenocarcinoma MCF-7 cells.
    Muehlmann LA; Rodrigues MC; Longo JP; Garcia MP; Py-Daniel KR; Veloso AB; de Souza PE; da Silva SW; Azevedo RB
    J Nanobiotechnology; 2015 May; 13():36. PubMed ID: 25966866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the therapeutic effect of photoactivated hematoporphyrin derivative and aluminum disulfonated phthalocyanines on tumor bearing mice.
    Canti G; Franco P; Marelli O; Cubeddu R; Taroni P; Ramponi R
    Cancer Lett; 1990 Sep; 53(2-3):123-7. PubMed ID: 2208071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and biodistribution of a theranostic aluminum phthalocyanine nanophotosensitizer.
    Asem H; El-Fattah AA; Nafee N; Zhao Y; Khalil L; Muhammed M; Hassan M; Kandil S
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():48-57. PubMed ID: 26708297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM; Wang KK; Zinsmeister AR
    Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
    Wang Y; Lin Y; Zhang HG; Zhu J
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.